Development of the Composition and Technology of Obtaining a Dental film with Portulaca oleracea extract

 

Meruyert I. Tleubayeva1*, Shynar Tukezhan1,

Gaukhar I. Yeshenkulova2, Aibala Daurenkyzy3, Raisa М. Abdullabekova4

1Department of Organization and Management and Economics of Pharmacy and Clinical Pharmacy,

School of Pharmacy, Kazakh National Мedical University named after S.D. Asfendiyarov, Almaty city,

St.Tole Bi 88, 050000, Kazakhstan.

2Astana IT University, Astana, Kazakhstan.

3Dentistry "One Dent", Dentist, Astana City, St. Zhenis 16, Kazakhstan.

4Departament of Pharmaceutical Disciplines and Chemistry, NJSC «Medical University of Karaganda», Karaganda city, st. Gogol 40, 100008, Kazakhstan.

*Corresponding Author E-mail: meruert_iliasovna@mail.ru

 

ABSTRACT:

According to the concept of the World Health Organization (WHO), oral health is the main indicator of the overall level of health and well-being, quality of life. Currently, improving oral health, treatment and prevention of chronic diseases of the mucous membrane are relevant. The creation of new dosage forms is an urgent problem, since existing dosage forms have both advantages and disadvantages. Dental film based on biologically active compounds of plant materials is a promising dosage form. The article presents the results of a study on the selection of ingredients for the rational composition of dental films based on carbon dioxide extract of Portulacaoleracea. Model formulations with various excipients have been developed for the selection of ingredients. In order to select the rational composition, a study was conducted on such characteristics as description, average mass, deviation from average mass, pH value, solubility, and the results of the study were described. The rational composition of the dental film with the conditional name "DentaPort" was established: the active substance is carbon dioxide extract of Portulaca oleracea, the formative substance is sodium alginate, a moisture-saving substance and a plasticizer is glycerin, powdered sugar is a corrigent, purified water is a solvent. The excipients were selected taking into account their compatibility with each other and the extract of Portulacaoleracea.

 

KEYWORDS: Carbon dioxide extract of Portulaca oleracea, Dental film, Oral cavity, Polymer, Models.

 

 


INTRODUCTION: 

Ensuring a healthy lifestyle and improving the well-being of people of all ages is an important component of sustainable development1.

 

According to the WHO, oral diseases affect 3.5 billion people around the world, and 3 out of 4 sufferers live in middle-income countries.

 

 

According to the concept of the WHO, oral healthis the main indicator of the overall level of health and well-being, quality of life. At the moment, the improvement of oral health, treatment and prevention of chronic diseases of the mucous membrane are the subject of study at the international level2,3,4. Oral diseases occupy the third place in the overall morbidity structure of the population of the Republic of Kazakhstan5.

 

According to world research data, periodontal disease ranked eleventh in the world6. It is considered one of the main causes of tooth loss, which compromises chewing and aesthetics, self-confidence and quality of life.7,8

 

 

In the prevention and treatment of inflammation of the mucous membrane of the oral cavity, not only the choice of the acting substance is important, but also the dosage form and the route of its administration.9,10

 

The range of dosage forms used in modern dental practice is wide: ointment, gel, paste, lozenges, spray, rinsing solutions, special toothpastes. Despite the variety of dosage forms for the treatment of oral diseases, it is currently important to create new dosage forms that provide high therapeutic activity with minimal side effects, with the possibility of regulating the duration of action9, 4. The creation of new dosage forms is an urgent problem, since existing dosage forms have both advantages and disadvantages.11,12

 

Dental film is one of the most promising dosage forms that allows to deliver drugs through the oral mucosa, control the kinetics of the release of active substances, prolong the therapeutic effect, combine medicinal drugs with different pharmacological and physico-chemical groups as part of a single composition. In addition, it is safe and convenient to use, and the patient can use it personally. 10,11,13,4,14

 

One of the main components of dental films is a polymer, which plays the role of a carrier (matrix) of medicinal preparationsand gives the dosage form the necessary structural-mechanical, technological, consumer properties. In the process of creating a dental film, synthetic, semi-synthetic, natural polymers are used as an auxiliary substance in different ratios and concentrations as a matrix. For this purpose, hydrophilic compounds with high mucoadhesic properties are often used: collagen, gelatin, cellulose, alginic acid derivatives, polyvinylpyrrolidone, polyvinyl alcohol.11,15-18

 

So, a medicinal film is a dosed solid medicinal drug mold in the form of a rectangular, oval or other shaped plate, consisting of one or more thin layers of usable size, which includes one or more drugs, excipients, film-former, plasticizer, preservative.16,17,19

 

Phytofilms containing biologically active substances obtained from plant raw materials are a type of transdermal therapeutic systems. Phytofilms are hydrophilic systems that, when in contact with water or biological fluids, absorb it in a certain amount and contribute to the dissolution of biologically active substances. Medicinal phytofilms differ from synthetic polymer therapeutic systems in that they are made as matrix transdermal therapeutic systems in natural carriers (agar-agar, gelatin, collagen, sodium alginate, etc.). Therefore, the safety and compatibility of phytofilms with living organisms is high.17,20

According to WHO estimates, 80% of the world’s population relies on traditional medicine. Medicinal plants are considered one of the main resources of traditional medicine and an important source of many modern medicines.21-24

 

The global market for plant-based products is estimated at $83 billion and is growing. Plant components have the ability to prevent the development of some chronic diseases. Showing a synergistic effect, medicinal plants show certain pharmacological and therapeutic properties21,25. Plants and natural products are widely used in pharmaceutical production, as they form the basis of traditional and modern medicine26.

 

Modern advances in dentistry have contributedto the use of various herbal and natural products for the treatment of oral diseases4,27.

 

One of the plants of great interest for official medicine and pharmacy is the Portulaca oleracea L. the plant, the component composition of which is rich in biologically active substances, is widely used in folk medicine in many countries as an anti-inflammatory, antipyretic, reducing sugar levels, cardiovascular diseases, gastrointestinal diseases28,29.

 

Ahn et al. reported that Portulaca oleacea L. exhibits various pharmacological effects, such as antibacterial, antifungal, anti-inflammatory, antioxidant and anti-ulcer effects, which are the result of various active components, including alkaloids, fatty acids, flavonoids, polysaccharides and terpenoids30.

 

Our results of the previous study show that the main groups of compounds for the carbon dioxide extract of Portulaca oleacea were established triterpenoids: Lupeol, β-Amyrin, γ-Sitosterol; phytosterols: Campesterol, Stigmasterol; diterpenes Phytol; Vitamin E; monounsaturated fatty acids 9,12-Octadecadienoic acid, ethyl ester, Linoleic, Ethyl linolenate, Linoleic acid, methyl ester, Ethyl-9,12-octadecadienoate, 9,12-Octadecadienoic acid; polyunsaturated fatty acids Linolenic acid, Ethyl icosanoate; fatty acids Hexadecanoic acid, Palmitic acid, methyl ester, Palmitic acid, ethyl ester, Palmitic acid, of which terpenoids make up 18.30%, fatty acids 34.11%28. Thus, the rich component composition of medicinal plant Portulaca oleracea L. can be used for the development of new herbal medicines.

 

In connection with the above, we set the goal of developing the rational composition and technology of dental film based on the carbon dioxide extract of Portulaca oleracea.

 

MATERIALS AND METHODS:

The research work was carried out on the basis of the NJSC «Kazakh National Medical University named after S.D. Asfendiyarov» of the Republic of Kazakhstan. 

 

Materials:

For research work, we selected the carbon dioxide extract of Portulaca oleracea as the active ingredient due to its antibacterial and antioxidant properties28,31. To choose the rational composition of the dental film, we selected auxiliary substances that meet the requirements of regulatory documents. Polyvinyl alcohol, sodium alginate, sodium carboxymethylcellulose, gelatin were used as a formative substance, glycerin as a moisture-saving substance and plasticizer, powdered sugar as a corrigent, purified water as a solvent. The excipients were selected taking into account their compatibility with each other and the carbon dioxide extract of Portulaca oleracea.

 

Methods:

The methods of controlling the organoleptic (according to the description of its shape, color, smell), physico-chemical parameters of the dental film were used. The length, width and thickness were measured using a micrometer.

 

Experimental:

Preparation of model samples:

All developed model samples are different in composition, and the preparation of all ten models is the same. To prepare a solution of polymers: sodium alginate – 3,4,5 models, polyvinyl alcohol – 1,2 models, sodium carboxymethylcellulose – 6,7 models, gelatin – 8,9,10 models were weighed on scales of the brand Ohaus AV264C (USA, assembled in China), placed in a glass beaker, filled with purified water and left to swell for 30-45 minutes. The swollen mass was heated in WB-4MS (Russia) stirred water bath until a transparent solution was obtained.  Glycerin, powdered sugar were added to the transparent solution and mixed.

 

After the introduction of the active substance into the polymer solution, the homogenization of the mass was carried out by stirring for an hour. Centrifuged in a centrifuge brand CM-6M (Latvia) for two hours to remove air bubbles.

 

We have chosen the most common and often used casting method for the development of films. The resulting mass was poured into a plastic mold. Drying was carried out at room temperature for 48 hours. The resulting film was cut into separate films with a size of 20x10x0.25mm.

 

Evaluation of the quality of dental film based on Portulaca oleracea extract:

Average mass and deviation from the average mass:

The test was carried out on 20 samples of films prepared on the basis of Portulaca oleracea extract. Each film was measured on the Ohaus AV264C laboratory analytical scale with an accuracy of 0.0001g and the average mass was calculated. The deviation of the films from the average mass should not exceed ±10%.

 

Decomposion: In distilled water should not be more than 15 minutes.

 

Dissolution: The test was carried out using the "rotating basket" apparatus (Erweka, Germany), dissolution medium – water, volume – 900ml, speed of rotation of blades – 100rpm, temperature - 37°C±0.5, dissolution time – 45min.

 

Weight loss during drying: Drying was carried out at atmospheric pressure, at room temperature. Dental films were weighed on laboratory electronic scales Ohaus Av264C, placed on glass pads and dried in a desiccator. Films were measured after 2, 4, 6, 8 and 24hours.

 

pH solution: The dental film was dissolved in 20ml of distilled water and the pH value (827 pH lab, Switzerland) was determined. The experiment was conducted at room temperature.

 

Microbiological purity: The sum of aerobic bacteria and fungi is not more than 102. Pseudomonas aeruginosa and Staphylococcus aureus should not be present.

 

Determination of adhesion: An arm balance scale is used to determine the adhesion of the films. On one side of the lever of the scale there is a plate for the weight, and on the other side there is a glass plate balanced with it. The studied samples are placed on a glass surface with a drop of water in advance using a micropipette. The sample is covered with the glass plate attached to the lever of the scale, pressed with a standard load of 100 g for 10 seconds. Gradually increase the mass of the load on the plate until the film does not detach from the glass plate.

 

RESULTS AND DISCUSSION:

Development of the rational composition of the dental film based on the Portulaca oleracea extract:

We have developed model compositions of dental films with carbon dioxide extract of Portulaca oleracea. In all samples of dental film, carbon dioxide extract of Portulaca oleracea was taken in the amount of 1.0 g. In order to create the rational composition of dental films, we have developed model samples of films (Table 1). 

 


Table 1: Models of dental films with carbon dioxide extract of Portulaca oleracea

Ingredients

№1

№2

№3

№4

№5

№6

№7

№8

№9

№10

Сarbon dioxide extract of Portulaca oleracea

1

1

1

1

1

1

1

1

1

1

Polyvinyl alcohol, g

7.0

10.0

-

-

-

-

-

-

-

-

Sodium alginate, g

-

-

2.0

4.0

5.0

-

-

-

-

-

Sodium carboxymethylcellulose, g

-

-

-

-

-

7.0

10.0

-

-

-

Gelatin, g

-

-

-

-

-

-

-

7.0

10.0

20.0

Glycerin, g

2.0

3.0

6.0

6.0

4.0

2.0

6.0

2.0

3.0

4.0

Powdered sugar, g

2.0

2.0

2.0

2.0

2.0

2.0

2.0

2.0

2.0

2.0

Purified water, up to 100 ml

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

 


Description of the mass and individual dental films:

During the production of the mass and after the production of individual films, we described the formed films. The results of the research are presented in table 2.

 

Table 2: Description of the mass and individual dental films

Model

Description of the mass and formed film

Cut into individual films

Model 1

It had an inhomogeneous consistency and did not provide smooth contact with the tissues

The film layer hasn’t formed

Model 2

Thick and lacked flexibility

The film layer hasn’t formed

Model 3

Thin and fat

The film layer was torn, during cutting

Model 4

Smooth, transparent, colorless and homogeneous

Easy

Model 5

Tight and not elastic enough

With uneven layer

Model 6

Hard, not elastic

The film layer broke, during cutting

Model 7

Hard, not elastic

The film layer broke, during cutting

Model 8

Lost a lot of weight during drying

The film layer hasn’t formed

Model 9

Smooth, transparent, colorless and homogeneous

Easy

Model 10

Although initially showing elasticity, after some time it hardened and broke during bending

The layer broke, during cutting

 

According to models No.1, No.2 polyvinyl alcohol-based films were uneven. The model No.1, which contained 7g of polyvinyl alcohol, had an inhomogeneous consistency and did not provide a sufficient degree of adhesion and smooth contact with the tissues, while model No.2, consisting of 10 g of polyvinyl alcohol, did not have much thickness and elasticity.

 

The models No. 6, No.7 based on sodium carboxymethylcellulose also did not satisfy the technological parameters, in particular, it was hard, inelastic, and difficult to remove from the lining.

 

The gelatin-based model No. 8 lost a lot of weight during drying, and the model No.10, although initially elastic, hardened after some time and broke during bending. In addition, the final sample became sharp after drying, which, in turn, caused the risk of slicing during use in the oral cavity.

 

The model No.3 prepared on the basis of sodium alginate, turned out to be thin and greasy. This sample contained a high amount of plasticizer. Therefore, it was considered to reduce the amount of glycerin in the following samples. The model No. 5 was rather dense and not elastic enough.

 

According to the results of the conducted research, models No.4 and No.9 had satisfactory technological indicators. The properties of sodium alginate and gelatin as film-forming are practically similar, but considering that the bleeding ability of alginic acid and its salts is important in the treatment of oral mucosa, we chose model No.4.

 

Determination of quality indicators of dental film based on Portulaca oleracea extract:

Based on the description, film dimensions, average mass, decomposition and dissolution time, weight loss during drying, microbiological purity, pH, the quality indicators of dental film based on the Portulaca oleracea extract were determined, the results are shown in table 3.

 

Table 3: Quality indicators of dental film based on Portulaca oleracea extract

Quality indicators

Deviation norms, research results

Description

Light orange color, with a characteristic smell of the garden purslane plant, without slices, air bubbles, elastic, homogeneous plates

Film dimensions

Width (10±0,2) mm, length (20±0,2), thickness (0,251±0,5) mm

Average mass

0,105±0,079g

Decomposition

814±5 sec

Dissolution

30min

Weight loss during drying

Not more 5±0,5%

Microbiological purity

The sum of aerobic bacteria and fungi is not more than 102. Pseudomonas aeruginosa and Staphylococcus aureuswere not be detected in 1g of the drug.

pH solution

6,68

 

Most of the group of biologically active substances used in pharmaceutical practice are natural products. Therefore, it is important to expand the range of medicinal and therapeutic and cosmetic products of plant origin. Thus, in the work of Himansu Bhusan Samolet al, it was reported about the development of a dental film containing aloe vera for the treatment of periodontal diseases4. The observed effect is in good agreement with the results of the research developed by Alekseeva I.V. et al, in whose works it was reported that the composition and technology of phytofilms based on polymer materials using dry plant extracts with antibacterial, wound healing and anti-inflammatory properties9. This is consistent with our research results.

 

Thus, as a result of the conducted research, the fourth model was selected as the optimal composition of the dental film with carbon dioxide extract of Portulaca oleracea and the conditional name "DentaPort" was assigned (Table 4).

 

Table 4: The rational composition of dental film "DentaPort"

Ingredient name

Quantitative size

Functional purpose

Сarbon dioxide extract of Portulaca oleracea

1.0

Active substance

Sodium alginate, g

4.0

Film forming

Glycerin, g

6.0

Plasticizer

Powdered sugar, g

2.0

Seasoning

Purified water, up to 100 ml

100.0

Solvent

 

Compared to some complex and expensive processes used in the production of various dosage forms, dental films are relatively easy to produce, a fast and inexpensive process15,19. Therefore, dental films obtained from medicinal plants are relevant and economical.

 

CONCLUSION:

The rational composition of the dental film has been developed on the basis of the technological process, which consists of the stages of preparation of raw materials, base, homogenization, pouring of the film mass into the lining, drying of the films, cutting. Dental film based on sodium alginate had good physical and chemical properties.

 

Dental film "DentaPort" is recommended for the treatment of diseases of the oral cavity and the formation of further technological processes.

 

CONFLICTS OF INTEREST:

The authors declare that there are no conflicts of interest regarding the publication of this article.

 

ACKNOWLEDGMENTS:

The authors express their gratitude to the staff of the School of Pharmacy NJSC “S.D. Asfendiyarov Kazakh National Medical University’’ of the Republic of Kazakhstan.

 

REFERENCES:

1.      Sustainable development Goals: Ensuring healthy lifestyles and promoting well-being for all at all ages. https://www.un.org/sustainabledevelopment/ru/health/

2.      World Health Organization. Oral health:https://www.who.int › Newsroom › Fact sheets › Detail

3.      NihaNaveed, KarthikeyanMurthykumar, SubasreeSoundarajan, SripradhaSrinivasan. The Use of Neem in Oral Health. Research J. Pharm. and Tech. 2014 Sept.;7(9):1060-1064.

4.      HimansuBhusanSamal, ItishreeJogamaya Das, Ch. NiranjanPatra, P. N. Murthy. Design and Development of Dental Film Containing Aloe vera for the Treatment of Human Periodontal Diseases. Asian J. Pharm. Tech. 2015; 5(4): 273-280. doi: 10.5958/2231-5713.2015.00036.7

5.      ВОЗ: кариес зубов лидирует среди неинфекционных заболеваний населения / Медицина Здоровье ВОЗ 2021 URL: https://strategy2050.kz/ru/news/voz-karies-zubov-lidiruet-sredi-neinfektsionnykh-zabolevaniy-naseleniya/(InRuss.)

6.      Lancet (Editorial). GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.

7.      Tonetti MS, Jepsen S, Jin LJ, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: a call for global action. Journal of Clinical Periodontology. 2017; 44(5): 456–462. doi: 10.1111/jcpe.12732.

8.      Reynolds I, Duane B. Periodontal disease has an impact on patients’ quality of life. Evidence-Based Dentistry. 2018; 19(1): 14–15. doi: 10.1038/sj.ebd.6401287.

9.      Alekseeva IV, Solovyeva KL, Veselkova TA. Development of technology and quality evaluation phytofilms based dry plant extracts. Modern Problems of Science and Education. 2012;5. URL: https://science-education.ru/ru/article/view?id=7174 (date of the application: 25.08.2022).(In Russ.)

10.   Averyanov SV, Khairzamanova K.A., Iskhakov I.R., Isaeva A.I. The use of dental films in diseases of the oral mucosa.Successes of Modern Sciences, 2017; 5(1): 99-104.(In Russ.)

11.   Sampiev A.M., Nikiforova EB, Sopovskaya AV. Current status of the study of dental films. International Journal of Applied and Fundamental Research. 2016;3:293-297. (In Russ.)

12.   Firsova IV, FedotovaYuM, Porojskij SV, MakedonovaYuA, Mihalchenko VF. Еfficiency of topical application of mucoadhesive drugs for treating red flat lichen of the oral cavity. Journal of Volgograd State Medical University.2019;1(69):59-64.(In Russ.)

13.   Narayana PR, Kumar MS, Reddy M, Ravishankar K. Formulation and Evaluation of Fast Dissolving Films of Loratidine by Solvent Casting method. Pharm Innova J. 2013;2(2):31-35.

14.   Choudhary NG, Syed AM, Kale VV, Avari JG. Oral Sustained Release in Situ Gel Forming Polymeric Drug Delivery Systems. Research J. Pharm. and Tech. 2010;3(3):682-687.

15.   Khan MA, Pandey GK, Joshi A, Dubey BK, Jain A K, Parkhe G. Fast Dissolving Oral Film: A Modern Development In Drug Delivery System. International Journal of Pharmaceutics and Drug Research. 2018;.6 (2):01-14

16.   Kishchenko VM, Vernikovsky VV, Privalov IM, Shevchenko AM. Films in russian medicine and cosmetology: development history, classification, technology. Pharmacy and Pharmacology. 2020; 8(2): 124-132. DOI: 10.19163/2307-9266-2020-8-2-124-132

17.   Shestakov NV, Losenkova SO, Zakalyukin EV, Stepanova EF. Range and characteristics transmucosal dosage forms. Drug Development and Registration. 2017; 2(19): 96-101. (In Russ.) https://www.pharmjournal.ru/jour/article/view/413?locale=en_US

18.   Ch.Prabhakar, K. Bala Krishna. A Review on Polymeric Nanoparticles. Research J. Pharm. and Tech. 2011; 4(4): 496-498. https://rjptonline.org/AbstractView.aspx?PID=2011-4-4-12

19.   Chonkar Ankita D., Bhagawati S. T., Udupa N.An Overview on Fast Dissolving Oral Films.Asian J. Pharm. Tech.  2015; 5(3): 129-137. DOI: 10.5958/2231-5713.2015.00020.3

20.   Kalmath K. V., Swamy H. K. S., Inamdar S. S.. Polymeric Transdermal Drug    Delivery Films of Iso-Sorbide Dinitrate. Research J. Pharm. and Tech. 2010; 3(4): 1175-1177. https://rjptonline.org/AbstractView.aspx?PID=2010-3-4-150

21.   Aatifa Rasool, Khalid Mushtaq Bhat, Altaf Ahmed Sheikh, Aarifa Jan and Shaziya. Medicinal plants: Role, distribution and future Hassan. Journal of Pharmacognosy and Phytochemistry. 2020;9(2):2111-2114.

22.   Arti Gautam, Swarnakshi Upadhyay. Formulation and Standardization of Polyherbal Face Wash Gel for Acne Management. Research J. Pharm. and Tech. 2022; 15(9): 3931-5. doi: 10.52711/0974-360X.2022.00658

23.   Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel. Pharmacognostical Standardization and Phytochemical Analysis of Chlorophytumborivilianum Santapau and R.R. Fern. Leaves. Research Journal of Pharmacy and Technology. 2022; 15(6):2402-6. doi: 10.52711/0974-360X.2022.00399

24.   Nuha Rasheed, Syed Abdul Rahman, Samreen Hafsa. Formulation and Evaluation of Herbal Lipsticks. Research J. Pharm. and Tech. 2020; 13(4): 1693-1700. doi: 10.5958/0974-360X.2020.00306.6

25.   Javad Sharifi-Rad, Cristina Quispe, Jesús Herrera-Bravo, Muhammad Akram, Wafa Abbaass, PrabhakarSemwal, Sakshi Painuli, Dmitry Alekseevich Konovalov, Mary Angelia Alfred, Nanjangud Venkatesh Anil Kumar, Muhammad Imran, Muhammad Nadeem, Barbara Sawicka, PiotrPszczółkowski, Bernadetta Bienia, PiotrBarbaś, Shafi Mahmud, Alessandra Durazzo, Massimo Lucarini, Antonello Santini, Miquel Martorell, Daniela Calina. Phytochemical Constituents, Biological Activities, and Health-Promoting Effects of the Melissa officinalis.Oxidative Medicine and Cellular Longevity 2021; Article ID 6584693, 20 pages. https://doi.org/10.1155/2021/6584693

26.   Borel Ndezo Bisso, Roland Njikang Epie Nkwelle, Roland Tchuenguem Tchuenteu, Jean Paul Dzoyem. Phytochemical Screening, Antioxidant, and Antimicrobial Activities of Seven Underinvestigated Medicinal Plants against Microbial Pathogens. Advances in Pharmacological and Pharmaceutical Sciences. 2022; Article ID 1998808, 8 pages. https://doi.org/10.1155/2022/1998808

27.   Ahmed Hilal Sheriff, Preetham Prasad Nittla. Dental Waxes–A Review. Research J. Pharm. and Tech. 2019; 12(11): 5589-5594. doi: 10.5958/0974-360X.2019.00968.5

28.   Tleubayeva M I, Datkhayev UM, Alimzhanova M, Ishmuratova MYu, Korotetskaya NV, Abdullabekova RM, Flisyuk EV, Gemejiyeva NG.Component Composition and Antimicrobial Activity of CO2 Extract of Portulacaoleracea, Growing in the Territory of Kazakhstan. The Scientific World Journal. 2021;| Article ID 5434525. https://doi.org/10.1155/2021/5434525

29.   Ajay Kumar, Sajana Sreedharan, Arun Kumar Kashyap, Pardeep Singh, Nirala Ramchiary. A review on bioactive phytochemicals and ethnopharmacological potential of purslane (Portulacaoleracea L.). Heliyon. 2022; 8(e08669) https://doi.org/10.1016/j.heliyon.2021.e08669

30.   Ahn E-Y, Lee YJ, Park J, Chun P, Park Y. Antioxidant Potential of Artemisia capillaris, Portulacaoleracea, and Prunella vulgaris Extracts for Biofabrication of Gold Nanoparticles and Cytotoxicity Assessment. Nanoscale Research Letters. 2018; 13: 348. https://doi.org/10.1186/s11671-018-2751-7

31.   Tleubayeva MI, Abdullabekova RM, Datkhayev UM, Ishmuratova MYu, Alimzhanova MB, Kozhanova KK, Seitaliyeva AM, Zhakipbekov KS, Iskakova ZhB, Serikbayeva EA, Flisyuk EV. Investigation of CO2 Extract of Portulaca oleracea for Antioxidant Activity from Raw Material Cultivated in Kazakhstan. International Journal of Biomaterials. 2022; Article ID 6478977; 11 pages. https://doi.org/10.1155/2022/6478977

 

 

 

 

 

Received on 23.01.2023            Modified on 26.08.2023

Accepted on 15.01.2024           © RJPT All right reserved

Research J. Pharm. and Tech 2024; 17(2):619-624.

DOI: 10.52711/0974-360X.2024.00096